GS
PACB icon

GTS Securities’s Pacific Biosciences PACB Stock Holding History

GTS Securities’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-36,200
Closed -$61.5K – 3230
2024
Q3 		$61.5K Sell
36,200
-3,400
-9% -$5.59K ﹤0.01% 3865
2024
Q2 		$54.3K Sell
39,600
-21,500
-35% -$43.4K ﹤0.01% 3700
2024
Q1 		$229K Sell
61,100
-298,700
-83% -$1.75M ﹤0.01% 3234
2023
Q4 		$3.53M Sell
359,800
-25,900
-7% -$212K 0.01% 1242
2023
Q3 		$3.22M Buy
+385,700
New +$4.41M 0.01% 1193

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GTS Securities's PACB Position: Q1 2026 in Review

GTS Securities opened a new position in Pacific Biosciences (PACB) in Q1 2026: 17,133 shares worth $22.6K. The stake represents ﹤0.01% of the portfolio and ranks #1456 among its holdings. This is a return to the name: GTS Securities previously reported a position in PACB as recently as Q3 2025.

GTS Securities first reported a position in PACB in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.11M in Q4 2023. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • GTS Securities held 17,133 shares of Pacific Biosciences worth $22.6K as of Q1 2026.
  • Pacific Biosciences was a new GTS Securities position in Q1 2026.
  • Pacific Biosciences made up ﹤0.01% of GTS Securities's portfolio in Q1 2026, its #1456 holding.
  • GTS Securities first reported a position in Pacific Biosciences in Q2 2023 and has held it in 9 quarters since.
  • GTS Securities's Pacific Biosciences position peaked at $3.11M in Q4 2023.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.